Name: Gynecology 2023
Start: 2023-02-06
End: 2023-02-08
Location: France

Renowned Speakers

We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.

Eleni Zoe Gkoritsa

Independent Researcher Greece

Biography

Elena Sarcina

Laboratory Director of the San Luca Medical Center Italy

Biography

Dr. Basma Abdulrahman Darwish

Consultant OBS and Gynecologist Bahrain

Andreea Gresanu

Gynecologist (Ob-Gyn) Germany

Conference Information

About Us

Pulsus Group

The Pulsus Group, a renowned peer-review publisher of scientific, technical, and medical journals, has acquired Andrew John Publishing and openaccessjournals.com in order to expand its open access publishing through its 50+ journals in collaboration with 20+ international medical and scientific societies.

By creating a forum for discussing the prospects of future collaborations between universities, institutions, research bodies, organisations, and scientific societies from various countries through international CME/CPD accredited conferences and meetings, Pulsus has played a significant role in providing an invaluable channel for scientists and researchers to exchange ideas and research.

The Pulsus Group is a medical publisher that follows a strict peer-review process in an effort to lead by example in encouraging ethical, conventional medical research. The endorsements of illustrious organisations and groups, such as the Canadian Medical Society, are something that the Pulsus Group takes great satisfaction in. Pulsus Group frequently associates with the Canadian and other worldwide medical research associations as a fervent supporter of medical publishing. Numerous medical publications with an emphasis on fields like cardiology, integrative medicine, surgery, and reproductive medicine are published by this company. Pulsus group is closely associated with globally renowned academic and research societies like European Society of Gynecology, Canadian Society for Aesthetic Plastic Surgery, Groupe pour advancement Microcharge Canada, Canadian Society for Surgery of the Hand and also scientific societies like Medicine, Material Science, Physics, Chemistry, food research associations. It publishes a wide range of journals.

Market Analysis

Over 450 professionals in the fields of reproductive biology, gynaecology, assisted conception, and sexual health will attend Gynecology 2023, which will feature a cutting-edge programme of famous international speakers, specialised concurrent sessions, short paper, and poster presentations. The specific educational requirements of gynaecologists have been carefully considered in the planning of this conference. This year's agenda offers you the chance to take part in or arrange a workshop in addition to cutting-edge presentations and discussions.

Gynecology and Obstetrics Global Market Analysis:

During the anticipated period, the incidence of gynecology problems is anticipated to drive market expansion. The most prevalent conditions include uterine fibroids, endometriosis, Polycystic Ovary Syndrome (PCOS), adenomyosis, and adenomyosis. A 2021 Frontiers Journal article estimates that the prevalence of PCOS in the population-based pool ranges from 5 to 9% worldwide. Due to the increasing frequency of these illnesses, more regular checkups and surgical procedures are being performed.

In addition, it is anticipated that the number of surgical procedures such as female sterilisation, ablation, endoscopy, and laparoscopy and the use of disposable items will both increase. It is also anticipated that increased use of cutting-edge and creative technologies will fuel industry expansion.

At a compound annual growth rate (CAGR) of 9.4%, the market for women's health products is anticipated to increase from $30.81 billion in 2021 to $33.70 billion in 2022. With a cumulative annual growth rate (CAGR) of 8.4%, the market for women's health products is predicted to reach $46.55 billion in 2026.

Gynecology Devices Market by Hand Instrument (Vaginal Speculum, Tenaculum, Curettes, Trocars, Biopsy Forceps and Others), by Diagnostic Imaging System (Ultrasound and Mammography), and by Surgical Device (Gynecological Endoscopy Devices, Endometrial Ablation Devices, Fluid Management Systems, and Female Sterilization and Contraceptive Devices) Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021 The report estimates that the global market for gynaecological devices was valued at USD 14.50 billion in 2015 and is expected to grow to USD 19.50 billion by 2021, with a CAGR of around 5.0% between 2015 and 2021.

At a compound annual growth rate (CAGR) of 11.07%, the market for gynecological pharmaceuticals worldwide is anticipated to increase from $22.22 billion in 2020 to $24.68 billion in 2021. Gynecological illnesses and gynecological cancer instances among women are on the rise, which is primarily to blame for the growth. At a CAGR of 6.05%, the market is anticipated to reach $31.21 billion in 2025.

Women’s Health Market:

In 2010, there were 6.15 billion people on the planet, 49.7% of whom were women. By 2025, the same pattern is anticipated to continue. There will be 8.19 billion people on the planet by 2025, 49.5% of whom will be female. This projected number explains the market for women's health's development potential through 2025. Women typically experience rapid hormonal, physiological, and emotional changes throughout their lifetimes and generally live longer than males. This aspect is currently acting as a catalyst for giving better healthcare and education to women in all nations around the world.

The expansion of the women's health market is fuelled by the fact that all major nations periodically increase their healthcare budgets. The main element fuelling the market's rise is the rising awareness of birth control options in both developed and emerging nations. Again, government funding for contraception and other birth control options in underdeveloped countries may contribute to the market's expansion.

Europe – Gynecology Market Analysis:

Market of Europe North America is Expected to Hold the Largest Share in the Gynecological Devices Market Over the Forecast Period the North American region holds the largest share of the gynecological devices market because of the rising incidence of cancer related to gynaecology, the significant presence of device manufacturers, and technological advancements. The American Cancer Society estimates that 65,950 new cases of uterine corpus cancer will be detected in the United States in 2022. Cervical cancer, which is spreading quickly among American women, is the cancer that causes the greatest anxiety out of all the others. In the United States, 14,100 cases of cervical cancer are anticipated in 2023.

Additionally, according to the Canadian Cancer Society's 2022 update, 8,100 Canadian women are anticipated to receive a uterine cancer diagnosis in 2022. As a result, the growing prevalence of cancer is increasing the demand for gynaecological equipment nationwide. The development of the market for gynaecological devices is also anticipated to be fueled by additional elements like growing female awareness, an increase in the occurrence of gynecological ailments, and an advanced healthcare system. For instance, the National Cervical Cancer Coalition (NCCC) and its numerous local chapters around the nation raise awareness of cervical cancer, the Human Papillomavirus (HPV) infection, and the value of early detection during the month of January. Although NCCC chapters do events all year long, January is a month with a particular focus as chapters honour Cervical Health Awareness Month and work to raise awareness in their neighbourhoods. Additionally, the proliferation of rival companies, mergers, and acquisitions involving gynaecological equipment across the nation spurs market expansion.

For instance, in October 2021, Bolder Surgical, a privately held US company that offers advanced energy vessel sealing surgical devices, and Hologic, Inc., a world leader in women's health, signed a definitive agreement to buy the latter for about USD 160 million, subject to working capital and other customary closing adjustments. Bolder Surgical's complementary acquisition is likely to expand Hologic's portfolio of surgical products, which already includes the Access laparoscopic radiofrequency ablation system for the treatment of fibroids, the Mysore tissue removal devices for the treatment of intrauterine fibroids and polyps, the Nova Sure endometrial ablation system for the treatment of abnormal uterine bleeding, and the Fluent fluid management system for streamlining hysteroscopic procedures. In light of the aforementioned considerations, North America is anticipated to account for a sizeable portion of market revenue over the course of the projected year.

Market analysis of France and Paris:

First-time mothers' average age, growing public knowledge of in vitro fertilisation (IVF), and improvements in infertility detection technology France had a total of 1.88 births per woman in 2018, and 1.87 in 2019, according to the World Bank's fertility rate. Millions of people who are of reproductive age experience infertility, which has an effect on their families and communities. Infertility affects millions of people who are of reproductive age and has an effect on their families and communities. Therefore, it is anticipated that rising infertility rates and declining birth rates will propel market expansion. In addition, the market for ultrasound-guided infertility diagnosis and treatment monitoring services is anticipated to grow as more people adopt sedentary lifestyles, consume more alcohol, tobacco, and other intoxicants, experience more stress, live unhealthy lifestyles, and experience an increase in obesity cases. For instance, the World Health Organization (WHO) global report on changes in prevalence of tobacco use 2000–2025 estimates that in 2019, the tobacco usage rates among adults in France aged 15 and older were 36.0 for men and 33.2 for men. In 2018, it was estimated that 30.0 percent of women and 30.0 percent of men smoked cigarettes. As a result, it is anticipated that smoking and heavy tobacco consumption will have an impact on both male and female fertility, which will ultimately fuel market expansion in France.

Additionally, the Organisation for Economic Co-operation and Development (OECD) reports that nearly 40% of French people are overweight and roughly 1 in 10 people are obese (including obese). Within 10 years, the OECD predicts a further 10% rise in overweight rates. Additionally, about 40% of French women were overweight in 2019, with 17% of these women being obese, according to Eurostat. In obese women, anovulation and menstrual problems are more prevalent. Women who are fat or overweight have an increased chance of miscarrying. These women are more likely to experience subfecundity, infertility, complications during conception, miscarriage, and pregnancy. As a result, each of these factors has a significant impact on the market for ultrasonography infertility diagnosis and treatment in France. The market is growing as a result of technological developments in IVF and frozen embryo transfer.

For instance, a bill allowing lesbians and single women in France to obtain medically assisted reproduction for the first time was enacted by the Lower House of Parliament in June 2021. Access to fertility therapies like IVF and artificial insemination is therefore anticipated to accelerate the expansion of the market of France. The high cost of assisted reproductive technology, danger associated with IVF, and high cost of infertility diagnosis procedures, however, restrain market expansion. Instead, it is anticipated that government attempts to advance the infertility technology industry and raise consumer disposable income levels will provide lucrative chances for market expansion. Additionally, the spike in demand for cutting-edge medical technology to improve the effectiveness of treatments and ensure that babies are delivered without difficulty is anticipated to create new potential opportunities for the market. The care pathway and end user segments are used to segment the France ultrasound infertility diagnostic and treatment market. The market is divided into infertility diagnosis, punction, and treatment monitoring based on the care pathway.

Hysterosalpingo-foam sonography, hysterosonography, and hysterosonosalpyngography are additional subcategories of the infertility diagnostics section (HyFoSy). The punction segment is further divided into ultrasound-guided core-needle testicular biopsy and ultrasound-guided transvaginal needle aspiration/biopsy. Ovulation monitoring and services for frozen embryo transfers are also included in the treatment monitoring segment. Depending on the end user, the market is divided into ambulatory centres, private fertility clinics, and public hospitals with infertility departments. Each end user is further divided into the diagnostic, intervention, and monitoring care pathways for infertility. American Hospital of Paris, Amp Center St. Roch, Amp Natecia Lyon, Centre Chirugical (Pierre Cherest Clinic), Fertility Center-Parsi East, Hospital Cochin, Hospital Group Diaconesses Croix Saint-Simon, Maternité Des Bluets - Hospital Pierre Rouquès, Pointgyn-Pleasure, Ramsay Healthcare Limited, and other significant players are among those profiled in the study (Clinique De La Muette).

Scientific Sessions

TRACK 1: GYNECOLOGY AND OBSTETRICS

The female genital system is studied in gynecology and obstetrics. The area of medicine known as obstetrics is dedicated to treating women during pregnancy, childbirth, and the postpartum period. Gynecology may cover a wider range of topics and is focused on treating conditions that affect the female reproductive system and the overall health of girls. Women may be referred to as gynecologists in the early stages of pregnancy and as obstetricians in the later stages.

Reproductive endocrinology and infertility
Menopausal and geriatric gynecology
Pediatric Gynecology
Adolescent Gynecology

Associated Journals: International Journal of Gynecology & Obstetrics | American Journal of Obstetrics & Gynecology | European Journal of Obstetrics and Gynecology and Reproductive Biology | Journal of Clinical Gynecology and Obstetrics | Journal of Women’s Health | Gynecological Endocrinology | Journal of Obstetrics and Gynaecology Canada | Journal of Women Health Nursing

TRACK 2: OBSTETRIC ONCOLOGY

In gynecologic oncology, cancers of the female genital system, such as those of the ovaries, endometrium, uterus, cervix, Fallopian tubes, peritoneum, vagina, and vulva, are diagnosed and treated. The other members of your care team will collaborate closely with a gynaecological oncologist to customise treatments to your unique requirements, minimise side effects, and address issues like infertility or problems with sexual function.

Cancer Treatments
Prophylactic surgery
Targeted therapy
Hormone therapy & Immunotherapy

TRACK 3: GYNECOLOGICAL ENDOCRINOLOGY

The focus of gynaecological endocrinology is on treating conditions linked to menstruation, fertility, and menopause. A subspecialty that focuses on the biological causes of infertility and its development is known as reproductive endocrinology and fetal-placental neuroendocrine development. It has to do with how different endocrine glands in women are controlled and function, how reproductive events affect the system, and how endocrine disorders affect reproduction.

Polycystic ovary syndrome (PCOS)
Hyperprolactinemia
Ovulation disorders
Uterine fibroids
Endometriosis Turner syndrome Rett syndrome

TRACK 4: UROGYNECOLOGY

Urogynecology is a subspecialty of gynaecology and obstetrics that deals with reconstructive surgery and female pelvic medicine. In addition, the fields of plastic surgery include Urogynecology. As discussed in numerous gynecologic conferences and gynecologic meetings around the world, robotic-assisted surgery has advanced significantly over the past 20 years due to consistently improving technology.

Urinary incontinence
Pelvic Organ Prolapse
Fecal incontinence
Interstitial cystitis
Vesicovaginal and rectovaginal fistulas
Overactive bladder syndrome

TRACK 5: OBSTETRICAL SURGERY

In the recent study, three cases of bladder or ureteral injury per 1000 cases of operative laparoscopic cases were found in the recent study. Bladder damage is likely to happen when a suprapubic trocar is inserted or when the lower uterine segment is exposed during a hysterectomy. The infundibulopelvic ligament during uterine vessel ligation and the area near the uterosacral ligament during pelvic brim ligation are most likely to cause ureteral injury. When attempting to control persistent bleeding following ligation of those pedicles, careful skeletonization of the broad ligament can help prevent unintentional injury.

Cervical Cryosurgery
Dilation and Curettage (D&C)
Hysteroscopy
Colposcopy
Pelvic Laparoscopy
Loop electrosurgical excision procedure (LEEP)

TRACK 6: OBSTETRICS AND GYNECOLOGY NURSE

Gynecology and OB nurses, also known as OB/GYN nurses, are specially trained to provide medical assistance to women during pregnancy, labour, and childbirth as well as provide medical assistance to women who have health issues involving or affecting their systems. Given that OB/GYN nursing may be a broad field, nurses typically focus on a particular area, such as perinatal nursing, labour and delivery nursing, or gynaecology nursing in a doctor's office. Women receive care and support from OB/GYN nurses beginning at the beginning of their period and continuing through the climacteric. They talk to patients about contraception options and provide information on physical and sexual health, as well as promote preventative measures like mammograms and HPV vaccinations for the early detection of cancer.

TRACK 7: MIDWIFERY

The health science and profession of midwifery are focused on girls' sexual and reproductive health throughout their lives, as well as pregnancy, childbirth, and the postpartum period. The midwife's main responsibilities are to assist with labour and delivery. According to reports, obstetrical interventions during childbirth are becoming more commonplace. National caesarean rates in Taiwan, China, Brazil, Argentina, Chile, Mexico, and Puerto Rico, for example, range from 40 to 50 percent. The caesarean rate in the United States has increased from 23% to 29.1% since the first decade of the twenty-first century, while rates are in the mid-20% range in most of Europe, Canada, and Australia. Despite the fact that professional midwives attend the majority of births in some of these nations, they are biomedically socialised, occasionally overworked, and powerless to stop the rising tide of caesareans, which is primarily obstetrician-driven.

Diagnosis and Management of Women During Antenatal Period
Physiology Of Puerperium
Management of Women During Post-Natal Period
Prenatal Nutrition & Fetal Medicines
Neonatal Resuscitation

TRACK 8: REPRODUCTIVE MEDICINE

Reproductive medicine is the area of medicine that deals with the prevention, diagnosis, and treatment of reproductive issues. Enhancing and preserving the standard of reproductive health is the goal of reproductive medicine. The knowledge of reproductive anatomy, endocrinology, physiology, and pathology is the foundation of reproductive medicine. Prenatal medicine and postnatal medicine can be further subdivided under the umbrella of reproductive medicine. Sexual education, family planning, diseases of the reproductive system, birth control, infertility, and sexual dysfunction are among the topics covered by reproductive medicine. Reproductive medicine also evaluates ovulation, pregnancy, menstruation, menopause, and other gynaecological issues.

Menstrual abnormality
Micro vascular complications
Polycystic Ovarian Syndrome
Physiology of GNRH and Gonadotropin Secretion
Endometriosi

TRACK 9: SEXUAL AND REPRODUCTIVE HEALTH

Good sexual and reproductive health is important for women’s general health and wellbeing. It depends on their capacity to choose and decide about their lives, including when or whether to consider having children. Sexual and reproductive health encompasses more than just physical well-being; it also refers to the right to healthy and respectful relationships, inclusive, safe, and appropriate health services, access to accurate information, effective, and reasonably priced contraceptive methods, and timely support and services for unintended pregnancies.

Women must have access to services that will ensure a healthy pregnancy, safe delivery, and healthy baby once they decide to have children. Each person has the right to make their own decisions regarding their sexual and reproductive health. Together with partners, UNFPA works to ensure that everyone has access to birth control, sexual and reproductive health, and rights.

HIV/AIDS
Interstitial Cystitis
Polycystic Ovary Syndrome (PCOS)
Endometriosis
Uterine Fibroids

TRACK 10: INFERTILITY

Infertility is typically defined as the inability to become pregnant (or consider becoming pregnant) after one year of unprotected sex. Failure to become pregnant, become impregnated, or carry a pregnancy to term is referred to as infertility. There are many causes of infertility, some of which can be treated with medicine. If a woman has tried unsuccessfully to become pregnant for a year without using contraceptives, she is deemed to be infertile. If a man has too few sperm or if his sperm quality is too poor to even consider fusing with a woman's egg, he is considered to be infertile.

Blocked fallopian tubes
Celiac disease & kidney disease
Past ectopic (tubal) pregnancy
Pelvic inflammatory disease
Pituitary gland disorders

TRACK 11: MATERNAL & FETAL MEDICINE

Maternal-fetal medicine is a broad topic that is specialised in gynaecology. As a result, there are approximately 33 research institutes that work in this area, as well as some universities that train women to work in this field. In total, there are 160 universities that offer this exciting field, and it receives funding in the range of $30000 to $4000,000. Specialists in maternal-fetal medicine fall under the umbrella of obstetrics. They will conduct prenatal examinations, give treatments, and carry out operations. They'll work closely with paediatricians or neonatologists after the baby is born. Perinatologists help mothers who have pre-existing medical issues or pregnancy-related complications. Maternal-fetal medicine specialists are obstetrician-gynecologists who have completed an additional three years of specialised training in the evaluation and management of high-risk pregnancies.

Cervical Insufficiency
Recurrent Pregnancy Loss
Preterm Labor
Isoimmunization
Placenta Accreta

TRACK 12: ADOLESCENT GYNECOLOGY

Adolescent endocrinology, gynaecology, adolescent surgery, dermatology, psychiatry, public health medicine, and genetics are all subspecialties of the newly emerging field of adolescent gynaecology. Thus, it covers a wide range of illnesses, from infancy to adolescence. The adolescent, who is almost an adult and no longer a toddler, has a unique management issue outside of the usual specialties. More so than anywhere else in the field of adolescent gynaecology, the medical attitude is frequently startling in its extremes.

TRACK 13: ADVANCEMENTS IN GENECOLOGY AND OBSTETRICS

This track will examine and discuss the most recent developments in tocology and the field of specialisation in medicine. Increased genetic testing, awareness of the Zika and dengue fever viruses, pregnancy-related stroke deaths linked to toxaemia, cannabis use and tocology outcomes, the prevalence of obesity in teen and adult women, and the sharp increase in caesarean deliveries are all examples of advances in women's health. Obstetricians and medical specialists must be aware of and demonstrate the appropriate knowledge, abilities, and attitudes to evaluate women through clinical history gathering, physical examinations, and lower limb examinations for both pregnant and non-pregnant women.

TRACK 14: GYNECOLOGY SURGERY

Gynecologic surgery includes operations on the vagina, cervix, uterus, fallopian tubes, and ovaries, as well as other reproductive organs in females. Gynecologic surgeons frequently perform procedures on a woman's bladder as well as the rest of the female urinary system.

Tubal ligation (tubes tied)
Removal of ovarian cysts (non-cancerous growths on an ovary)
Removal of cysts or fibroids (non-cancerous growths) in the uterus
Removal of growths from the cervix (the lower part of the uterus that connects to the vagina)
Uterine artery embolization, which cuts off the blood supply to a uterine fibroid so it gets smaller

TRACK 15: MENSTRUAL CYCLE & MENOPAUSE

The end of a woman's menstrual cycle is known as menopause. Any changes you go through just before or after your period ends, signalling the end of your reproductive years. Your body may go through a number of subtle and not-so-subtle changes as you transition into menopause. Periods with irregular timing could happen. As ovulation becomes more unpredictable, your period interval may be longer or shorter, your flow may be light or heavy, and you may skip some cycles.

Perimenopause
Menopause
Post menopause

TRACK 16: BREAST CANCER

Breast cancer is a type of cancer that develops in the breast cells. The second commonest cancer in women to be diagnosed in the United States is breast cancer. carcinoma diagnosis and treatment have advanced thanks to significant funding for research and awareness campaigns. With earlier detection, a replacement personalised approach to treatment, and a far better understanding of the disease, carcinoma survival rates have improved and the number of deaths linked to the disease is steadily declining.

Angiosarcoma
Ductal carcinoma in place (DCIS)
Inflammatory carcinoma
Invasive lobular carcinoma
Lobular carcinoma in place (LCIS)
Paget's disease of the breast
Recurrent carcinoma

TRACK 17: GENETIC SCREENING AND GENETIC TESTING

A genetic test looks for gene changes in a person. Genetic diseases can result from gene changes (also called genetic disorders). They may also increase a person's risk of developing certain medical conditions (like some cancers). There are some genetic diseases that can run in families.

People undergo genetic testing to determine whether they themselves have genetic changes or whether they can pass genetic changes to their offspring.

Cayman fibrosis
Tay-Sachs condition
a sickle cell diagnosis
Spina bifida and Down syndrome
Albinism, von Willebrand disease, and the Turner syndrome
Muscular dystrophy in Duchenne

TRACK 18: GESTATIONAL DIABETES

When diabetes is discovered for the first time while pregnant, it is called gestational diabetes (gestation). Gestational diabetes affects how your cells use sugar, similar to other types of diabetes (glucose). High blood sugar levels brought on by gestational diabetes can harm both you and your unborn child's health.

There is good news, even though any pregnancy complication is alarming. Gestational diabetes can be managed during pregnancy by eating well, exercising, and, if necessary, taking medication. Blood sugar management can ensure the health of both you and your unborn child and avoid a challenging delivery.If you have gestational diabetes during pregnancy, your blood sugar typically returns to normal soon after delivery.

Type 2 Diabetes

TRACK 19: REPRODUCTIVE CLONING

The process of reproductive cloning involves inserting a cloned embryo into a real or made-up uterus. A foetus develops from the embryo and is then carried to term. The embryo splitting method, in which a single early-stage two-cell embryo is manually divided into two individual cells and then grows as two identical embryos, has been used for reproductive cloning procedures for more than 40 years. Reproductive cloning methods underwent significant modification in the 1990s as a result of Dolly's birth, who was produced using the SCNT procedure. Reproductive cloning is a method for producing an exact duplicate of a multicellular organism. The majority of multicellular organisms reproduce sexually, which involves the genetic blending of two different people (parents), making it impossible to create an exact replica or clone of either parent.

somatic cell nuclear transfer
embryo splitting
DNA in embryo splitting

TRACK 20: ENDOMETRIOSIS

Endometriosis is a condition in which tissue that typically lines the inside of your uterus grows outside of your uterus. The tissue lining your pelvis, fallopian tubes, and ovaries are all frequently affected by endometriosis.

Each menstrual cycle causes the endometrial-like tissue in endometriosis to thicken, degrade, and bleed just like endometrial tissue would. However, this tissue becomes trapped because it has nowhere to go but inside your body. Endometriomas, or endometrial cysts, can develop when endometriosis affects the ovaries. Scar tissue and adhesions, bands of fibrous tissue that can cause pelvic tissues and organs to adhere to one another, can form when surrounding tissue becomes irritated.

dysmenorrhea
Pain with bowel movements or urination
Infertility

TRACK 21: HERBAL MEDICINE

Currently, there is a rise in the use of herbal remedies and prenatal care. Herbs like chamomile, ginger, valerian, bitter kola, peppermint, cranberry, raspberry leaf, thyme, green tea, sage, garlic, anise, and fenugreek are some of the most popularly used during pregnancy. The use of herbal remedies during pregnancy depends on the woman's age, level of education, and income. When treating nausea and vomiting, lowering the risk of gestational diabetes and preeclampsia, treating a urinary tract infection, and treating a cold, herbal medications are frequently chosen. Rarely using herbal remedies while pregnant can lead to issues like allergic reactions, increased blood flow, abortion, miscarriage, heartburn, and early labour. If herbal medicine is recommended during the first trimester, it is unsafe for the foetus. There is always the recommendation to consult a professional before using any herbal remedies while pregnant. Additional research is required to demonstrate the unfavourable effects of herbal medicine and treatments.

Advantages of herbal remedies for pregnancy
Make wholesome decisions to avoid birth defects
Reduced pregnancy pain with herbs
Insemination herbs

TRACK 22: MENSTRUATION AND VESTIBULAR MIGRAINE

Menstrual migraines are a type of hormonal headache that occur just before or during your period. They occur because progesterone and oestrogen levels fall right before the start of your period. People who have a history of migraine symptoms may experience frequent dizziness (or vertigo) due to a vestibular migraine, a neurological system disorder. In contrast to typical migraines, you might not constantly feel pain. This kind of issue goes by many names. Your doctor may also diagnose you with migraine-related vestibulopathy, migraine-associated vertigo, or migraineous vertigo.

About Conference

The European Conference on Psychosomatic Obstetrics and Gynecology (ECPOG) which will be held during February 06-08, 2023 in Paris, France. As the Conference of ECPOG 2023. Gynecology 2023 is sponsored by Pulsus with the theme of “The hunting manifesto for Psychosomatic Obstetrics and Gynecology”. It aims to be one of the leading international conferences for presenting novel and fundamental advances in the fields of Gynecology, Obstetrics and Women’s Health. It also serves to foster communication among researchers and practitioners working in a wide variety of scientific areas with a common interest in improving Gynecology, Obstetrics & Women’s Health related techniques. The conference is the world largest Gynecology Conference and Gathering for the Research Community, Join the Gynecology & Obstetrics Congress at Paris, France.

Benefits:

Meet the esteemed professionals from around the world.
Increase a Knowledge in Gynecology
Potential Networking Contacts
Each respective Supporting Conferences Journal will publish each accepted abstract.
A Digital Object Identification Number (DOI), provided by CrossRef Certification, will be given to each accepted abstract

Recommendations for Authors

Please make sure your submission complies with the stringent requirements for scholarly paper acceptance at the conference. versions of the check list for full-text papers and abstract papers that can be downloaded.Before submitting your paper, please review the Author Information, Paper Submission Guidelines, and Abstract Submission Guidelines.

Who Can Attend?

Gynecologists
Surgeons
Oncologists
Radiologists
Scientists and Professors
Women’s Healthcare Researchers
Healthcare Faculty
Medical Colleges
Healthcare Associations and Societies
Business Entrepreneurs

Metrics

One of the most notable scientific conference organisers in the world, Pulsus Group has a unique perspective on every aspect of science, technology, and business. How well a conference series reaches the online community in particular determines a portion of its overall success. Now a days many women begin seeing a gynaecologist in their early teens and continue to do so as well as continue to go to well-woman clinics for other health-related issues. Women are advised to see a gynaecologist for a check-up once a year and whenever they experience any unsettling symptoms. The Conference visitor (users) graph you can see the analytics to develop the department of Gynecology.

European Conference on
Psychosomatic Obstetrics and Gynecology (ECPOG)

Quick Links

Theme: